The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sequential or up-front triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma (AIO-MONTBLANC): Safety interim analysis.
 
Najib Ben Khaled
Honoraria - AstraZeneca
Consulting or Advisory Role - Ipsen; Roche
Research Funding - AstraZeneca; Genentech; Roche (Inst)
Other Relationship - GASL Scientific Committee; UEG Scientific Committee
 
Ursula Ehmer
Honoraria - AstraZeneca; Eisai; Falk Foundation; Ipsen; MSD; Novartis
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai
Travel, Accommodations, Expenses - AstraZeneca; Biotest
 
Ilja Kubisch
Honoraria - Alynalam; AstraZeneca
 
Maria Gonzalez-Carmona
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; MSD; Roche; SERVIER
 
Alexander Philipp
Honoraria - AstraZeneca; Falk Foundation; Ipsen; Pfizer
Consulting or Advisory Role - MSD; Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Max Seidensticker
Stock and Other Ownership Interests - AstraZeneca; Novartis; Roche
Honoraria - AstraZeneca; Bayer; Cook Medical; Roche; Siemens Healthineers; SIRTEX Medical
Research Funding - AstraZeneca (Inst); Boston Scientific (Inst); SIRTEX Medical (Inst)
 
Andreas Geier
Consulting or Advisory Role - Abbvie; Advanz Pharma; Albireo Pharma; Alexion Pharmaceuticals; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Falk Pharma; Gilead Sciences; Heel; Intercept Pharmaceuticals; Ipsen; Merz Pharma; MSD; Novartis; Pfizer; Roche; Sanofi Aventis GmbH
Speakers' Bureau - Abbvie; Advanz Pharma; Alexion Pharmaceuticals; Bristol-Myers Squibb; Burgenstein; CSL Behring; Falk Pharma; Gilead Sciences; Intercept Pharmaceuticals; Merz GmbH; MSD
Research Funding - Falk Foundation; Intercept Pharmaceuticals; Novartis
 
Caterina Soldà
No Relationships to Disclose
 
Alessandra Auriemma
No Relationships to Disclose
 
Kornelius Schulze
Consulting or Advisory Role - AstraZeneca; MSD; Roche
Speakers' Bureau - AstraZeneca; MSD; Roche
 
Lorenzo Antonuzzo
Honoraria - Amgen; AstraZeneca; Novartis; Roche
Consulting or Advisory Role - Merck Serono; MSD Oncology
 
Gianluca Masi
Consulting or Advisory Role - AstraZeneca; Eisai; MSD Oncology; Roche; Roche; TERUMO
Research Funding - Terumo (Inst); Terumo (Inst)
Patents, Royalties, Other Intellectual Property - Terumo (Inst)
 
Bruno Daniele
Honoraria - AstraZeneca; Eisai; Incyte; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Roche; Xenthera Inc.
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD
 
Jens Ricke
No Relationships to Disclose
 
Julia Mayerle
No Relationships to Disclose
 
Friedrich Foerster
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Roche; SERVIER
Speakers' Bureau - AstraZeneca; Lilly
Travel, Accommodations, Expenses - SERVIER
 
Florian Reiter
Honoraria - Abbvie; AstraZeneca; Falk Foundation; Gilead Sciences; Ipsen; Novartis; Roche
 
Thomas Ettrich
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Takeda
Research Funding - Baxalta/Shire; Lilly (Inst)
Travel, Accommodations, Expenses - Ipsen; Lilly
 
Enrico De Toni
Employment - Boehringer Ingelheim
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Pfizer; Roche; TERUMO
Research Funding - AstraZeneca; Bayer; Bristol-Myer Squibb; Ipsen; Lilly; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; IPSEN; Roche